Clinical trial
Neurodevelopmental Effects of Antiepileptic Drugs II: the NEAD Study
NCT00021866 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurodevelopmental Effects of Antiepileptic Drugs II: the NEAD Study
- Lead sponsor
- Emory University
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2000
- Completion date
- August 31, 2012
- Enrollment
- 331 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
cognition disorders, epilepsy, seizure